XML 26 R16.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 10 - Stock-based Compensation
6 Months Ended
Jun. 30, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Note
10
.
Stock-Based Compensation
 
Stock Options Plans
 
The Company has long-term compensation plans that permit the granting of incentive awards in the form of stock options. Generally, the terms of these plans require that the exercise price of the options
may
not
be less than the fair market value of Celsion’s common stock on the date the options are granted. Options granted generally vest over various time frames or upon milestone accomplishments.  The Company’s options generally expire
ten
years from the date of the grant.
 
The Celsion Corporation
2007
Stock Incentive Plan (the
2007
Plan), as adopted and amended, permits the granting of
688,531shares
of stock as equity awards in the form of incentive stock options, nonqualified stock options, restricted stock, restricted stock units, stock appreciation rights, phantom stock, and performance awards, or in any combination of the foregoing.  
 
In
2007,
the Company adopted the Celsion Corporation
2007
Stock Incentive Plan (the
2007
Plan) under which
15,873
shares were authorized for issuance. The purpose of the
2007
Plan is to promote the long-term growth and profitability of the Company by providing incentives to improve stockholder value and enable the Company to attract, retain and reward the best available persons for positions of substantial responsibility.  The
2007
Plan permits the granting of equity awards in the form of incentive stock options, nonqualified stock options, restricted stock, restricted stock units, stock appreciation rights, phantom stock, and performance awards, or in any combination of the foregoing.  At the Annual Meetings of Stockholders of Celsion held on
June 25, 2010,
June 7, 2012,
June 20, 2014,
and
May 16, 2017
the stockholders approved amendments to the Plan.  The only material difference between the original Plan and the amended Plan was the number of shares of common stock available for issuance under the amended Plan which was increased by
15,873
to a total of
31,746
shares in
2010,
by
35,714
to a total of
67,460
shares in
2012,
by
178,571
to a total of
246,031
shares in
2014
and by
442,500
to a total of
688,531
shares in
2017.
 
Prior to the adoption of the
2007
Plan, the Company adopted
two
stock plans for directors, officers and employees (
one
in
2001
and another in
2004
) under which
21,164
shares collectively were reserved for future issuance under both of these plans.  As these plans have been superseded by the
2007
Plan, any options previously granted which expire, forfeit, or cancel under these plans will be rolled into the
2007
Plan.
 
A summary of the Company’s stock option and restricted stock awards for the
six
months ended
June 30, 2017
is as follows: 
 
 
 
Stock Options
 
 
Restricted Stock
Awards
 
 
Weighted
Average
 
Equity Awards
 
Options
Outstanding
 
 
Weighted
Average
Exercise
Price
 
 
Non-vested
Restricted
Stock
Outstanding
 
 
Weighted
Average
Grant
Date
Fair Value
 
 
Contractual
Terms of
Equity
Awards
(in years)
 
                                         
Equity awards outstanding at December 31, 2016
   
210,023
    $
59.77
     
4,785
    $
37.42
     
 
 
                                         
Equity awards granted
   
513,464
    $
2.69
     
     
     
 
 
                                         
Equity awards forfeited, cancelled or expired
   
(42,545
)
  $
157.97
     
(1,428
)
  $
26.18
     
 
 
                                         
Equity awards outstanding at June 30, 2017
   
680,942
    $
10.59
     
3,357
    $
42.20
     
9.38
 
                                         
Aggregate intrinsic value of outstanding awards at June 30,2017
  $
     
 
    $
6,882
     
 
     
 
 
                                         
Equity awards exercisable at
June 30, 2017
   
405,075
    $
14.97
     
 
     
 
     
9.10
 
                                         
Aggregate intrinsic value of awards exercisable at
June 30, 2017
  $
     
 
     
 
     
 
     
 
 
 
The fair values of stock options granted were estimated at the date of grant using the Black-Scholes option pricing model. The Black-Scholes model was originally developed for use in estimating the fair value of traded options, which have different characteristics from Celsion’s stock options. The model is also sensitive to changes in assumptions, which can materially affect the fair value estimate.  
 
The Company used the following assumptions for determining the fair value of options granted during the
six
month periods of
2017
and
2016
under the Black-Scholes option pricing model:
 
 
 
Six Months Ended
June 30
,
 
 
 
201
7
 
 
201
6
 
Risk-free interest rate
   
2.21
%
   
1.87
%
Expected volatility
   
90.4
%
   
89.1
%
Expected life (in years)
   
10.00
     
10.00
 
Expected forfeiture rate
   
%
   
10
%
Expected dividend yield
   
%
   
%
 
Expected volatilities utilized in the model are based on historical volatility of the Company’s stock price. The risk free interest rate is derived from values assigned to U.S. Treasury bonds with terms that approximate the expected option lives in effect at the time of grant. The model incorporates exercise, pre-vesting and post-vesting forfeiture assumptions based on analysis of historical data. The expiration of each option granted in fiscal
2017
and
2016
was used as the expected life.
 
Total compensation cost related to employee stock options and restricted stock awards totaled
$676,918
and
$283,186
for the
three
months ended
June 30, 2017
and
2016,
respectively.  Total compensation cost related to employee stock options and restricted stock awards totaled
$804,592
and
$898,520
for the
six
months ended
June 30, 2017
and
2016,
respectively. 
No
compensation cost related to share-based payments arrangements was capitalized as part of the cost of any asset as of
June 30, 2017
and
2016.
 
As of
June 30, 2017,
there was
$0.6
million of total unrecognized compensation cost related to non-vested share-based compensation arrangements. That cost is expected to be recognized over a weighted-average period of
1.4
years. The weighted average grant-date fair value was
$2.32
and
$15.93
per share for the options granted during the
six
months ended
June 30, 2017
and
2016,
respectively.  The weighted average grant-date fair value was
$18.62
for the restricted stock awards granted during
six
months ended
June 30, 2016.  
 
Collectively, for all of the Company’s stock option plans there were a total of
24,951
equity awards available for future issuance as of
June 30, 2017.